1 / 5

Case Study by Amarjit Mishra Assistant Professor Asthma Heterogeneity & Potential Therapeutic Candidates

Amarjit Mishra is working to improve our understanding of the mechanism by which metabolic reprogramming occurs in the case of asthma patients and identify target metabolites for therapeutic intervention for the asthma patients.u00a0<br>

amarjitmishraasstprof
Download Presentation

Case Study by Amarjit Mishra Assistant Professor Asthma Heterogeneity & Potential Therapeutic Candidates

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Case Study by Amarjit Mishra Assistant Professor Asthma Heterogeneity & Potential Therapeutic Candidates .Amarjit Mishra of Auburn University has been playing a crucial role in helping to develop a better understanding of asthma and its many manifestations. Let’s learn more about Amarjit Mishra and how his work is influencing other researchers’ understanding of the causes and potential therapeutic targets of asthma heterogeneity.

  2. He is an accomplished researcher in the fields of immunology and pulmonology. In addition to being a well-known academician, Amarjit Mishra has participated in numerous projects approved by the National Institute of Health of the USA and made a name for himself in the field of biological sciences.

  3. Amarjit Mishra has made a groundbreaking discovery in one of his key publications, highlighting that the selective targeting of metabolic reprogramming can function as a potential therapy option for asthma. In order to further clarify the situation, Amarjit Mishra has drawn attention to previous studies that showed metabolic regulators involved in multiple catabolic and anabolic pathways could be one of the most promising therapeutic options for the treatment of asthma endotypes.

  4. Peroxisome proliferator-activated receptor gamma, also known as PPAR-γ or Pioglitazone, is a thiazolidinedione-type diabetes medication that stimulates the transcription factor involved in glucose and lipid metabolism. The role of the peroxisome proliferator-activated receptors, PPAR-α and PPAR-γ, in the control of antigen-induced airway inflammation, eosinophil inflow, generation of Th2 cytokines, and AHR in the experimental model of asthma has long been known.

  5. Amarjit Mishra is working to improve our understanding of the mechanism by which metabolic reprogramming occurs in the case of asthma patients and identify target metabolites for therapeutic intervention for the asthma patients. Source:- https://webvk.in/case-study-by-amarjit-mishra-assistant-professor-asthma-heterogeneity-potential-therapeutic-candidates/

More Related